Hyderabad, April 26: Omnicare Drugs India Pvt Ltd, a 100 per cent subsidiary of the UAE's largest pharmaceutical manufacturer Neopharma LLC, and ASKA Pharmaceuticals Co, a top pharma brand in Japan, will jointly set up a manufacturing facility in Visakhapatnam.
The two companies on Thursday announced entering into an agreement to establish a joint venture (JV) in India for the purpose of manufacturing and marketing of pharmaceuticals to global market.
The focus of this state-of-the-art facility, which will come up by 2020 at the cost of Rs 350 crore, will be to manufacture oral solid dosage forms, oral liquids and topical preparations. It will have a peak capacity to manufacture 3 billion tablets a year, said a statement.
Neopharma and ASKA Pharma will be taking accreditation from all the major global health regulatory bodies.
The manufacturing plant under this JV agreement will be based at JN Pharma City in Andhra Pradesh's Visakhapatnam. The project will go on floor next month while the operations are likely to start by 2020.
The focus will be to manufacture products targeting chronic therapies in cardiovascular diseases, central nervous system and diabetes along with other drugs from key therapeutic classes targeting Japan and world market.
"The partnership will enable us to transfer skills and knowledge locally," said B.R. Shetty, Neopharma Founder and Chairman.
N. Suresh Kumar, Neopharma COO, said: "We are entering into a strategic relationship with ASKA Pharmaceuticals to accelerate growth in regulated markets of the US and the European Union and in the emerging markets Africa and Asia."
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi (PTI): Fifteen flights were diverted at the Delhi airport early Saturday morning as low visibility due to dense fog impacted operations for the second straight day.
Due to the adverse weather conditions, many flights were delayed and the country's largest airline IndiGo temporarily put arrivals and departures on hold.
An official said 15 flights were diverted at the airport between 12.15 am and 1.30 am due to reduced visibility.
"While landing and takeoffs continue at Delhi Airport, flights that are not CAT III compliant may get affected. Passengers are requested to contact the airline concerned for updated flight information. Any inconvenience caused is deeply regretted," the Delhi International Airport Ltd (DIAL) said in a post on X at 6.56 am.
CAT III facility allows aircraft to operate in low visibility conditions.
Delhi's Indira Gandhi International Airport (IGIA) is operated by DIAL.
"#6ETravelAdvisory: Departures and arrivals at #DelhiAirport are currently on hold due to reduced visibility," IndiGo said in a post on X at 1.05 am on Saturday.
Air India said in an update on X at 1.16 am that poor visibility due to dense fog is impacting flight operations in Delhi and parts of northern India.
A thick blanket of fog had enveloped Delhi on Friday as well, delaying more than 400 flights.